Your browser doesn't support javascript.
loading
Survey of current retinopathy of prematurity practices in China.
Le, Thao Phuong; Feng, Jing; Ding, Leona; Hu, Rong; Lou, Xiao-Bo; Ulrich, J Niklas; Cabrera, Michelle T.
Affiliation
  • Le TP; Eye Associates Northwest P.C., Seattle, Washington 98104-1306, USA.
  • Feng J; Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
  • Ding L; Department of Ophthalmology, University of Washington, Seattle, WA 98195-0005, USA.
  • Hu R; Department of Ophthalmology, Hunan People's Hospital, Changsha 410005, Hunan Province, China.
  • Lou XB; Department of Ophthalmology, Hunan People's Hospital, Changsha 410005, Hunan Province, China.
  • Ulrich JN; Department of Ophthalmology, University of North Carolina, Chapel Hill, NC 27515, USA.
  • Cabrera MT; Department of Ophthalmology, University of Washington, Seattle, WA 98195-0005, USA.
Int J Ophthalmol ; 14(8): 1241-1247, 2021.
Article in En | MEDLINE | ID: mdl-34414091
ABSTRACT

AIM:

To understand retinopathy of prematurity (ROP) screening and treatment preferences among Chinese ophthalmologists.

METHODS:

A Chinese language survey was administered anonymously using WebQ (Catalyst, Seattle, WA, USA) among Chinese ROP screeners from December 2016 to January 2017.

RESULTS:

Among 70 ophthalmologists contacted, 65 responded (93%; 78% female, mean age 40y, 57% pediatric ophthalmologists and 25% retina specialists). Most used screening criteria of birth weight ≤2 kg (62%) with variation in cut-off gestational age (≤37wk, 34%; ≤34wk, 22%; ≤32wk, 31%). RetCam (Natus Medical Incorporated, Pleasanton, CA, USA) wide-field fundus photography assisted most screeners (72%) and was exclusively used by many (29%). Among 55 ophthalmologists treating ROP, anti-vascular endothelial growth factor (VEGF) was preferred over laser for both zone I (76% vs 24%) and zone II ROP (58% vs 42%). Retina specialists (P=0.004) and ophthalmologists with >3mo of training (P=0.03) were more likely to use anti-VEGF over laser for zone I ROP. Lack of laser training (8/20, 40%), access (6/20, 30%) and anesthesia (4/20, 20%) were common barriers to laser treatment.

CONCLUSION:

Chinese ROP screeners favor anti-VEGF injection and RetCam imaging for ROP management. A better understanding of ROP screening and treatment informs future research and education efforts in China.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Ophthalmol Year: 2021 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Ophthalmol Year: 2021 Document type: Article Affiliation country: Estados Unidos